Cargando…

Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia

INTRODUCTION: Genomic testing is a relatively new, disruptive and complex health technology with multiple clinical applications in rare diseases, cancer and infection control. Genomic testing is increasingly being implemented into clinical practice, following regulatory approval, funding and adoptio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mordaunt, Dylan A, Stark, Zornitza, Santos Gonzalez, Francisco, Dalziel, Kim, Goranitis, Ilias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689401/ https://www.ncbi.nlm.nih.gov/pubmed/38030253 http://dx.doi.org/10.1136/bmjopen-2022-069441

Ejemplares similares

Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia
por: Mordaunt, Dylan A., et al.
Publicado: (2023)

Determining the utility of diagnostic genomics: a conceptual framework
por: Mallett, Andrew, et al.
Publicado: (2023)

Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol
por: Jayasinghe, Kushani, et al.
Publicado: (2019)

Two-step offer and return of multiple types of additional genomic findings to families after ultrarapid trio genomic testing in the acute care setting: a study protocol
por: Bouffler, Sophie E, et al.
Publicado: (2023)

Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases
por: Jayasinghe, Kushani, et al.
Publicado: (2021)

Microcosting study of ICU costs in three European countries
por: Tan, SS, et al.
Publicado: (2008)

Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
por: Ferreira, João P., et al.
Publicado: (2020)

Direct costs of radiotherapy for rectal cancer: a microcosting study
por: Hanly, Paul, et al.
Publicado: (2015)

The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments
por: Goranitis, Ilias, et al.
Publicado: (2020)

Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation
por: Hayeems, Robin Z, et al.
Publicado: (2022)

Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis: A Report of the Association for Molecular Pathology
por: Sabatini, Linda M., et al.
Publicado: (2016)

Cost of managing atonic postpartum haemorrhage with uterine balloon tamponade devices in public health settings of Maharashtra, India: an economic microcosting study
por: Shetty, Siddesh Sitaram, et al.
Publicado: (2021)

The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
por: Schwarze, Katharina, et al.
Publicado: (2019)

Cost analysis of a mobile medical unit programme in Andhra Pradesh: a microcosting study protocol
por: Raikwar, Aakash Ashok, et al.
Publicado: (2021)

Epigenetic and genetic variation among three separate introductions of the house sparrow (Passer domesticus) into Australia
por: Sheldon, E. L., et al.
Publicado: (2018)

Microcosting Analysis of Diffuse Large B-Cell Lymphoma Treatment in Malawi
por: Painschab, Matthew S., et al.
Publicado: (2019)

EE335 A Multicenter Microcosting Study for COVID-19 in Brazil
por: Bertoglio Cardoso, R., et al.
Publicado: (2023)

Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening
por: Nghiem, V T, et al.
Publicado: (2015)

Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group
por: Hrifach, Abdelbaste, et al.
Publicado: (2016)

Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol
por: Peters, Jaime L, et al.
Publicado: (2015)

Rare variants increase the risk of severe COVID-19
por: van de Veerdonk, Frank L, et al.
Publicado: (2021)

Rare variants contribute disproportionately to quantitative trait variation in yeast
por: Bloom, Joshua S, et al.
Publicado: (2019)

Cohesin residency determines chromatin loop patterns
por: Costantino, Lorenzo, et al.
Publicado: (2020)

Assessing the cost-effectiveness of precision medicine: protocol for a systematic review and meta-analysis
por: Chen, Wenjia, et al.
Publicado: (2022)

An intronic polymorphic deletion in the PTEN gene: implications for molecular diagnostic testing
por: Sandell, S, et al.
Publicado: (2013)

Regulatory network structure determines patterns of intermolecular epistasis
por: Lagator, Mato, et al.
Publicado: (2017)

Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice
por: Heinzerling, L, et al.
Publicado: (2013)

Cost of integrating assisted partner services in HIV testing services in Kisumu and Homa Bay counties, Kenya: a microcosting study
por: Wamuti, Beatrice, et al.
Publicado: (2022)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

Aspirin-induced nuclear translocation of NFκB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency
por: Din, F V N, et al.
Publicado: (2005)

Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases
por: Kwon, Young Mi, et al.
Publicado: (2018)

DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
por: Lee, S, et al.
Publicado: (2010)

Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome
por: Khan, Kashif Aziz, et al.
Publicado: (2020)

A microcosting study of microsurgery, LINAC radiosurgery, and gamma knife radiosurgery in meningioma patients
por: Tan, Siok Swan, et al.
Publicado: (2010)

A Checklist for the Conduct, Reporting, and Appraisal of Microcosting Studies in Health Care: Protocol Development
por: Ruger, Jennifer Prah, et al.
Publicado: (2016)

Estimating maternity ward birth attendant time use in India: a microcosting study
por: Lofgren, Katherine T, et al.
Publicado: (2022)

A microcosting analysis of ICU expenditure in the interval between brain death and organ donation
por: Bowtell, Meghan K., et al.
Publicado: (2023)

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours
por: Özdağ, H, et al.
Publicado: (2002)

Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease
por: Rajasekaran, Surender, et al.
Publicado: (2021)

Reassessment of weak parent-of-origin expression bias shows it rarely exists outside of known imprinted regions
por: Edwards, Carol A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tc24t71kd25ncuhh0p1iumgrt1